LABRIE, Fernand,SINGH, Shankar,LABRECQUE, Richard,CIOBANU, Liviu Constantin
申请号：
HK16111768.9
公开号：
HK1223609A
申请日:
2016.10.12
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
Compounds having the structure or their salts: are used to treat or reduce the likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia, male baldness, muscle atrophy and weakness, sarcopenia, male hypogonadism, erectile dysfunction, female sexual dysfunction and osteoporosis. They can be formulated together with pharmaceutically acceptable diluent or carrier or otherwise made into any pharmaceutical dosage form. Combinations with other active pharmaceutical agents are also disclosed.
